Net Income (Loss) Attributable to Parent in USD of PROKIDNEY CORP. from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
PROKIDNEY CORP. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2021 to Q3 2025.
  • PROKIDNEY CORP. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$16,469,000.000, a 8.05% increase year-over-year.
  • PROKIDNEY CORP. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$71,033,000.000, a 55.7% decline year-over-year.
  • PROKIDNEY CORP. annual Net Income (Loss) Attributable to Parent for 2024 was -$61,186,000.000, a 72.5% decline from 2023.
  • PROKIDNEY CORP. annual Net Income (Loss) Attributable to Parent for 2023 was -$35,468,000.000.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

PROKIDNEY CORP. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$71,033,000 -$16,469,000 +$1,441,000 +8% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 -$72,474,000 -$16,552,000 -$4,046,000 -32.4% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 -$68,428,000 -$16,734,000 -$7,242,000 -76.3% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q4 2024 -$61,186,000 -$21,278,000 -$15,577,000 -2.7% 01 Oct 2024 31 Dec 2024 10-K 17 Mar 2025
Q3 2024 -$45,609,000 -$17,910,000 -$6,926,000 -63.1% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 -$38,683,000 -$12,506,000 -$3,388,000 -37.2% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 -$35,295,000 -$9,492,000 +$173,000 +1.8% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025
Q4 2023 -$35,468,000 -$5,701,000 01 Oct 2023 31 Dec 2023 10-K 17 Mar 2025
Q3 2023 -$10,984,000 +$18,946,000 +63.3% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$9,118,000 -$6,847,986 -3% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024
Q1 2023 -$9,665,000 -$5,683,975 -1.4% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q3 2022 -$91,069,224 -$29,930,000 -$29,677,510 -117.5% 11 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 -$61,391,714 -$2,270,014 -$2,269,871 01 Apr 2022 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 -$59,121,843 -$3,981,025 -$3,975,843 01 Jan 2022 31 Mar 2022 10-Q 12 Aug 2022
Q4 2021 -$55,146,000 -$54,888,185 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2024
Q3 2021 -$252,490 01 Jul 2021 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 -$143* 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 -$5,182* 25 Feb 2021 31 Mar 2021 10-Q 12 Aug 2022

PROKIDNEY CORP. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$61,186,000 -$25,718,000 -72.5% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025
2023 -$35,468,000 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025
2021 -$55,146,000 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.